Median levels in patients with IS [19.1 pmol/L (IQR 11.2–48.5)] and in patients with stroke-mimics [33.31 pmol/L (IQR 7.57–255.7)] were higher than copeptin-levels in patients with TIA [9.4 pmol/L (IQR 5.4–13.8)] (p = 0.081; p = 0.153, resp., Figure 1). This evidence concerns the gene AVP and stroke disorder.